The purpose of this study was to probe whether baseline circulating Lp(a) and apoC-III levels are associated with the development of renal impairment in type 2 diabetes mellitus (T2DM) patients, a population already at increased risk for adverse CV and renal outcomes [2, 9–18]. The gene discussed is APOC3; the disease is diabetes mellitus.